Comparative Orthopaedic Research Laboratory, Département de Sciences Cliniques, Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, Quebec, Canada.
Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.
Equine Vet J. 2022 Sep;54(5):989-998. doi: 10.1111/evj.13530. Epub 2021 Nov 18.
There is a knowledge gap about how equine MFC subchondral radiolucencies (SR) arise and evolve. Osteoclasts are believed to have a role but have not been studied in situ.
To measure and compare osteoclast density and the percentage of chondroclasts in healthy and MFC SR specimens from juvenile Thoroughbreds.
Cadaveric study.
Medial femoral condyles (MFC) from a tissue bank of equine stifles were studied. Inclusion criteria were MFCs (≤8 months old) with a computed tomography SR lesion and histological focal failure of endochondral ossification (L group). Contralateral, lesion-free, MFCs were a control group (CC). Osteochondral slabs were cut through the lesion (L), a healthy site immediately caudal to the lesion, (internal control; IC) and the contralateral, site-matched controls (CC). Histological sections were immunostained with Cathepsin K for osteoclast counting. Osteoclasts in contact with the growth cartilage (chondroclasts) were also counted. The sections were segmented into regions of interest (ROI) at different depths in the subchondral bone: ROI (0-1 mm), ROI (1-3 mm) and ROI (3-6 mm). Osteoclasts were counted and the bone area was measured in each ROI to calculate their density. Chondroclasts were counted in ROI .
Sections were studied from L and IC (n = 6) and CC sites (n = 5). Osteoclast density was significantly higher in ROI when compared with ROI in all groups. Although higher osteoclast density was measured in ROI in the L group, no significant differences were detected when compared with control ROIs. The proportion of chondroclasts in ROI was lower in the L sections when compared with controls but no significant differences were detected.
Limited sample size.
Osteoclasts are important actors in MFC subchondral bone development, digesting both growth cartilage (chondroclasts) and bone, but the pathophysiology of early MFC SRs cannot be explained solely by an increased osteoclast presence in the subchondral bone.
马股骨滑车(MFC)下骨透亮区(SR)的发生和演变机制尚不清楚。破骨细胞被认为在此过程中发挥作用,但尚未进行原位研究。
测量和比较幼年纯血马健康 MFC 滑车 SR 标本和 MFC 滑车 SR 标本中的破骨细胞密度和破软骨细胞比例。
尸体研究。
从马膝关节组织库中获取股骨滑车。纳入标准为:≤8 月龄、CT 存在 SR 病变且组织学显示存在软骨内骨化失败的 MFC(L 组);无病变、对侧 MFC 为对照组(CC)。从病变部位(L)、病变下方的健康部位(内部对照;IC)和对侧匹配部位(CC)获取骨软骨板。用组织蛋白酶 K 对切片进行免疫染色以计数破骨细胞。同时计数与生长软骨接触的破骨细胞(破软骨细胞)。将切片划分为不同深度的感兴趣区(ROI):ROI(0-1mm)、ROI(1-3mm)和 ROI(3-6mm)。在每个 ROI 中计算破骨细胞数量和骨面积,以计算破骨细胞密度。在 ROI 中计数破软骨细胞。
共研究了 6 个 L 和 IC 部位以及 5 个 CC 部位的切片。与所有组的 ROI 相比,ROI 的破骨细胞密度均显著更高。尽管 L 组 ROI 的破骨细胞密度更高,但与对照组 ROI 相比,差异无统计学意义。与对照组相比,L 组 ROI 的破软骨细胞比例较低,但差异无统计学意义。
样本量有限。
破骨细胞是 MFC 下骨发育的重要因素,可消化生长软骨(破软骨细胞)和骨,但早期 MFC SR 不能仅用骨下骨中破骨细胞的存在来解释其发病机制。